Capecitabine-induced terminal ileitis

Author:

Al-Gahmi Aboelkhair Mohammad1,Kerr Ian Graham1,Zekri Jamal Mohamed1,Zagnoon Abbas Abdulqader2

Affiliation:

1. Department of Oncology, King Faisal Specialist Hospital, Jeddah, Saudi Arabia

2. Department of Internal Medicine, King Faisal Specialist Hospital, Jeddah, Saudi Arabia

Publisher

King Faisal Specialist Hospital and Research Centre

Subject

General Medicine

Reference5 articles.

1. Design of a novel oral fluoropyrimidine, capecitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue;Miwa M;Eur J cancer,1998

2. First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin;Cassidy J;Ann Oncol,2002

3. UICC world Cancer Congress 2006)–abstract UICC world Cancer Congress 2006)–abstract Debora Barton Marcelo Cruz Vladimir Schraibman Ulcerative Ileitis Secondary to Adjuvant Capecitabine for Colon Cancer: A Case Report

4. Ileitis following capecitabine use. NedTijdschr Source :DeventerZiekenhuis, afd. InterneGeneeskunde, Deventer, the Netherlands;Bouma G;Geneeskd,2011

5. A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer;Hyodo I;Jpn J ClinOncol,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3